Pediatric Cancer Treatment Cost in India

When a child is diagnosed with cancer, the first thing most parents think about, after the initial shock settles, is “Can we afford this?” It is one of the most difficult questions a family can face, and it deserves a clear, honest answer.

The good news: India offers world-class pediatric cancer treatment at a fraction of the cost in the US, UK, or even Southeast Asia. With the right specialist and hospital, most families, both domestic and international, can access treatment that meets global standards.

This page breaks down the actual cost of pediatric cancer treatment in India in 2026, so you can plan without guesswork.

Why Families Choose India for Pediatric Cancer Treatment

Dedicated pediatric hemato-oncology units, internationally trained specialists, and access to advanced therapies like CAR-T cell therapy and haploidentical BMT have made India a genuine destination for childhood cancer care not just a budget alternative.

Key reasons families choose India:

• Pediatric cancer treatment cost in India is 60-80% lower than in the US or UK, for equivalent outcomes
• Pediatric-specific protocols are now standard at top centres
• Internationally trained specialists with fellowship training in pediatric haematology-oncology
• NABH- and JCI-accredited hospitals with dedicated paediatric BMT units

Overall Cost of Pediatric Cancer Treatment in India

Understanding the financial scope of treatment helps families plan with confidence. Below is a structured overview of pediatric cancer treatment costs in India.

Note: These are estimated ranges. Your child’s actual cost depends on cancer type, stage, response to treatment, duration of hospital stay, and whether a transplant is required.

Cancer-Specific Cost Breakdowns

Leukaemia (ALL and AML) Treatment Cost

ALL is the most common childhood cancer and, reassuringly, one of the most treatable. Overall survival rates above 85-90% are achievable with modern risk-stratified protocols.

• Standard-risk ALL (full 2-3 year protocol): ₹10,00,000 – ₹15,00,000
• High-risk ALL (requires intensification): ₹15,00,000 – ₹22,00,000
• Relapsed ALL (may require BMT or CAR-T): ₹25,00,000 – ₹50,00,000+
• AML (full treatment, no transplant): ₹8,00,000 – ₹14,00,000
• AML requiring BMT: ₹22,00,000 – ₹35,00,000

→ Understanding Blood Cancer in Children – symptoms, types, and what treatment involves.

Lymphoma Treatment Cost in Children

Childhood lymphoma, both Hodgkin and non-Hodgkin, generally responds very well to treatment, with cure rates exceeding 80-90% in many cases.

• Hodgkin Lymphoma (chemotherapy + possible radiation): ₹4,00,000 – ₹10,00,000
• Non-Hodgkin Lymphoma (intensive chemotherapy): ₹6,00,000 – ₹14,00,000
• Relapsed lymphoma (requiring BMT): ₹18,00,000 – ₹28,00,000

What Is Included in These Costs, and What Is Not

This is where most families get confused. A quoted “treatment cost” rarely means the same thing across hospitals. Here is what is typically included and excluded.

Usually Included:

• In-hospital stay
• Chemotherapy drugs
• Nursing care and monitoring
• Standard blood investigations during admission
• BMT unit stay during transplant (in packages)

Usually NOT Included:

• Pre-treatment diagnostic workup (bone marrow biopsy, genetic/molecular testing, PET/CT, MRI)
• Medications taken at home between cycles
• Growth factors (G-CSF), anti-fungals, and anti-virals
• Blood and platelet transfusions
• ICU charges if complications occur
• Post-treatment follow-up visits and monitoring
• Travel and accommodation (for outstation/international families)

Typical diagnostic workup before treatment begins: ₹50,000 – ₹2,00,000 depending on investigations required.

Factors That Affect the Final Cost

No two children’s treatment journeys are identical. Here are the variables that most significantly influence the total cost:

• Type and stage of cancer – High-risk or relapsed disease requires more intensive (and expensive) protocols than standard-risk disease caught early.
• Response to initial treatment – A child who achieves remission quickly after the first phase of chemotherapy will have a more predictable cost trajectory than one who needs treatment modification.
• Need for BMT – A bone marrow transplant, when required, often represents the single largest cost in the entire treatment journey.
• Complications – Infections during chemotherapy, febrile neutropenia episodes, and organ toxicity can extend hospitalisation and add substantially to costs.
• Duration of maintenance therapy – For ALL in particular, the 18-24 month maintenance phase, while relatively low-cost per month, adds up over time.

Why Treatment at a Dedicated Paediatric Oncology Unit Matters

This point is worth making clearly: children are not small adults when it comes to cancer treatment. Drug dosing, toxicity monitoring, supportive care, and long-term follow-up for late effects all require paediatric-specific expertise.

A child treated in a unit staffed by dedicated pediatric hemato-oncologists with experience in paediatric cancer protocols will receive a meaningfully different standard of care than one treated in a general oncology department.

The cost of treatment may be similar. The outcome often is not.

→ Learn more about Paediatric Bone Marrow Transplant and what distinguishes a child-specific BMT programme.

For International Patients: What to Expect

India has become a destination for families from across South Asia, the Middle East, Africa, and beyond. For international patients, the pediatric cancer treatment cost in India typically includes:

• Visa assistance
• Airport pickup and hospital liaison
• Translator support
• Accommodation options near the hospital

Cost comparison for international families (2026 estimates):

Even factoring in travel, accommodation, and extended stay, the cost savings for international families are substantial.

Getting a Personalised Cost Estimate for Pediatric Cancer Treatment

The most accurate estimate comes after a clinical review of your child’s case. To provide a meaningful cost assessment, a specialist will typically need:

• Pathology reports (biopsy, bone marrow report)
• Molecular/genetic testing results (FISH, cytogenetics, flow cytometry)
• Imaging (CT, MRI, PET-CT as relevant)
• Current treatment summary (if previously treated elsewhere)
• Complete blood count

With these documents, a detailed treatment plan including an estimated cost breakdown by phase can be prepared before you even travel.

Take the First Step Towards a Pediatric Cancer Treatment Plan

When a child is diagnosed with cancer, parents are suddenly expected to make complex medical decisions under emotional pressure, often without knowing where to begin. Having the right specialist by your side from day one makes that journey more navigable.

Dr. Satyendra Katewa is a globally recognised Pediatric Hemato-Oncologist and Bone Marrow Transplant specialist with over 25 years of clinical experience treating childhood blood cancers, bone marrow failure syndromes, leukaemia, lymphoma, thalassemia, and primary immunodeficiency disorders.

Currently Director of Haemato-Oncology & Bone Marrow Transplant at Max Healthcare, Delhi, Dr. Katewa has performed over 1,000 successful BMT procedures and treated more than 10,000 young patients across 30+ childhood conditions, including complex haploidentical and matched-unrelated donor transplants that few centres in India attempt.

His guiding philosophy is simple: every life is worth saving, and every smile is worth restoring.

If your child has received a diagnosis or you are seeking a second opinion, an early consultation can bring clarity on diagnosis, treatment options, expected outcomes, and a realistic cost roadmap.

📞 Book an Appointment or WhatsApp us directly for a faster response.